Latest filing published 12 Mar 2014 for JUNIPER PHARMACEUTICALS INC, €6.1M.
Insider track record
No signal scores available.
Actavis plc: trading record in brief
Actavis plc discloses dealings in Juniper Pharmaceuticals Inc to SEC (Form 4). Altogether 2 filings, all relating to 7 March 2014.
Sales make up the whole of the open-market record (2 sales, €12.0M).
Most recently, on 12 March 2014, the filings show an open-market sale worth €6.1M in Juniper Pharmaceuticals Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Actavis plc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,400,000 shares@ US$6.0779Common StockSEC:0001179110-14-005102:0
- 1,400,000 shares@ US$5.76Common StockSEC:0001179110-14-004981:0
2 of 2 declarations